These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 7567222

  • 21. Benign intracranial hypertension in an older child with cystic fibrosis.
    Lucidi V, Di Capua M, Rosati P, Papadatou B, Castro M.
    Pediatr Neurol; 1993; 9(6):494-5. PubMed ID: 7605562
    [Abstract] [Full Text] [Related]

  • 22. Increased intracranial pressure in cystic fibrosis.
    Katznelson D.
    Acta Paediatr Scand; 1978 Sep; 67(5):607-9. PubMed ID: 696306
    [Abstract] [Full Text] [Related]

  • 23. Cystic fibrosis with fibrosing colonopathy in the absence of pancreatic enzymes.
    Waters BL.
    Pediatr Dev Pathol; 1998 Sep; 1(1):74-8. PubMed ID: 10463274
    [Abstract] [Full Text] [Related]

  • 24. Hyperthyrotropinemia in newly diagnosed cystic fibrosis patients with pancreatic insufficiency reversed by enzyme therapy.
    Giannakopoulos A, Katelaris A, Noni M, Karakonstantakis T, Kanaka-Gantenbein C, Doudounakis S.
    Eur J Pediatr; 2018 May; 177(5):775-779. PubMed ID: 29487998
    [Abstract] [Full Text] [Related]

  • 25. Pancreatic enzyme supplementation as acid-resistant microspheres versus enteric-coated granules in cystic fibrosis. A double placebo-controlled cross-over study.
    Petersen W, Heilmann C, Garne S.
    Acta Paediatr Scand; 1987 Jan; 76(1):66-9. PubMed ID: 3551493
    [Abstract] [Full Text] [Related]

  • 26. Comparative effects of antacids, enteric coating, and bile salts on the efficacy of oral pancreatic enzyme therapy in cystic fibrosis.
    Nassif EG, Younoszai MK, Weinberger MM, Nassif CM.
    J Pediatr; 1981 Feb; 98(2):320-3. PubMed ID: 6906363
    [No Abstract] [Full Text] [Related]

  • 27. Clinical pharmacology of pancreatic enzymes in patients with cystic fibrosis and in vitro performance of microencapsulated formulations.
    Kraisinger M, Hochhaus G, Stecenko A, Bowser E, Hendeles L.
    J Clin Pharmacol; 1994 Feb; 34(2):158-66. PubMed ID: 8163716
    [Abstract] [Full Text] [Related]

  • 28. Cystic fibrosis colonopathy.
    Lloyd-Still JD, Beno DW, Kimura RM.
    Curr Gastroenterol Rep; 1999 Jun; 1(3):231-7. PubMed ID: 10980955
    [Abstract] [Full Text] [Related]

  • 29. Colonic strictures in cystic fibrosis.
    Taylor CJ.
    Lancet; 1994 Mar 12; 343(8898):615-6. PubMed ID: 7906805
    [No Abstract] [Full Text] [Related]

  • 30. Fibrosing colonopathy in cystic fibrosis.
    Smyth RL.
    Arch Dis Child; 1996 May 12; 74(5):464-8. PubMed ID: 8669970
    [Abstract] [Full Text] [Related]

  • 31. Comparison of four pancreatic extracts in cystic fibrosis.
    Beverley DW, Kelleher J, MacDonald A, Littlewood JM, Robinson T, Walters MP.
    Arch Dis Child; 1987 Jun 12; 62(6):564-8. PubMed ID: 3304172
    [Abstract] [Full Text] [Related]

  • 32. Hyperuricosuria due to high-dose pancreatic extract therapy in cystic fibrosis.
    Stapleton FB, Kennedy J, Nousia-Arvanitakis S, Linshaw MA.
    N Engl J Med; 1976 Jul 29; 295(5):246-8. PubMed ID: 934188
    [Abstract] [Full Text] [Related]

  • 33. Enteric coated microspheres of pancreatin in the treatment of cystic fibrosis: comparison with a standard enteric coated preparation.
    Stead RJ, Skypala I, Hodson ME, Batten JC.
    Thorax; 1987 Jul 29; 42(7):533-7. PubMed ID: 3326213
    [Abstract] [Full Text] [Related]

  • 34. Facial palsy and idiopathic intracranial hypertension in twins with cystic fibrosis and hypovitaminosis A.
    Obeid M, Price J, Sun L, Scantlebury MH, Overby P, Sidhu R, Chiriboga CA, Quittell LM.
    Pediatr Neurol; 2011 Feb 29; 44(2):150-2. PubMed ID: 21215918
    [Abstract] [Full Text] [Related]

  • 35. Monitoring pancreatin supplementation in cystic fibrosis patients with the 13C-Hiolein breath test: evidence for normalized fat assimilation with high dose pancreatin therapy.
    Braden B, Picard H, Caspary WF, Posselt HG, Lembcke B.
    Z Gastroenterol; 1997 Feb 29; 35(2):123-9. PubMed ID: 9066102
    [Abstract] [Full Text] [Related]

  • 36. Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis.
    Dutta SK, Hubbard VS, Appler M.
    Dig Dis Sci; 1988 Oct 29; 33(10):1237-44. PubMed ID: 3168696
    [Abstract] [Full Text] [Related]

  • 37. Porcine pancreatin as a source of salmonella infection in children with cystic fibrosis.
    Lipson A, Meikle H.
    Arch Dis Child; 1977 Jul 29; 52(7):569-72. PubMed ID: 879849
    [Abstract] [Full Text] [Related]

  • 38. Omeprazole enhances the efficacy of pancreatin (pancrease) in cystic fibrosis.
    Heijerman HG, Lamers CB, Bakker W.
    Ann Intern Med; 1991 Feb 01; 114(3):200-1. PubMed ID: 1984743
    [Abstract] [Full Text] [Related]

  • 39. Comparison of a high lipase pancreatic enzyme extract with a regular pancreatin preparation in adult cystic fibrosis patients.
    Gan KH, Heijerman HG, Geus WP, Bakker W, Lamers CB.
    Aliment Pharmacol Ther; 1994 Dec 01; 8(6):603-7. PubMed ID: 7696449
    [Abstract] [Full Text] [Related]

  • 40. Benign intracranial hypertension in infants with cystic fibrosis.
    Bikangaga P, Canny GJ.
    Arch Pediatr Adolesc Med; 1996 May 01; 150(5):551-2. PubMed ID: 8620242
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.